StockData

Acro Biomedical Co., Ltd. (ACBM) stock

ACBMOTCServices-Amusement & Recreation ServicesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$0.03+0.00 (0.00%)

Close on Oct 19, 2026Market cap $1.56MP/E –Yield –

Acro Biomedical operating margin

Operating margin is operating income as a percentage of revenue.

Acro Biomedical's operating margin for the twelve months ending Sep 30, 2023 was -3533.6%. For fiscal 2022 it was -2410.0%, against -642.5% the year before. The highest annual figure on record is 6.4% in fiscal 2018.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2022Dec 31, 2022-2410.0%−1767.5
FY2021Dec 31, 2021-642.5%−609.9
FY2019Sep 30, 2019-32.6%−39.0
FY2018Sep 30, 20186.4%+6.9
FY2017Sep 30, 2017-0.4%–

Quarterly operating margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q4 FY2022CQ4 2022Dec 31, 2022-1092.7%−1035.5
Q1 FY2022CQ1 2022Mar 31, 2022-1316.1%−1309.2
Q4 FY2021CQ4 2021Dec 31, 2021-644.2%−650.9
Q2 FY2021CQ2 2021Jun 30, 2021-158.7%−166.7
Q1 FY2021CQ1 2021Mar 31, 2021-57.3%−62.3
Q1 FY2019CQ4 2018Dec 31, 2018-7.0%−12.5
Q4 FY2018CQ3 2018Sep 30, 20186.7%–
Q3 FY2018CQ2 2018Jun 30, 20188.0%–
Q2 FY2018CQ1 2018Mar 31, 20185.0%–
Q1 FY2018CQ4 2017Dec 31, 20175.6%–

More Acro Biomedical figures

See a number that looks wrong?